Upstream / Downstream

Explore pathways related to this product.

Our U.S. Offices Will Be Closing Early

Our U.S. offices will be closing early on November 26th at 6:00 PM EST.

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
Phospho-Bcl-2 (Ser70) (5H2) Rabbit mAb 2827 40 µl
Western Blotting Immunofluorescence Flow Cytometry
H 28 Rabbit IgG
Phospho-Bcl-2 (Thr56) Antibody (Human Specific) 2875 40 µl
Western Blotting
H 28 Rabbit 
Bcl-2 (50E3) Rabbit mAb 2870 40 µl
Western Blotting Immunoprecipitation
H M R 26 Rabbit 
Bcl-xL (54H6) Rabbit mAb 2764 40 µl
Western Blotting Immunoprecipitation Immunohistochemistry Immunofluorescence Flow Cytometry
H M R Mk 30 Rabbit IgG
Mcl-1 (D35A5) Rabbit mAb 5453 40 µl
Western Blotting
H M Mk 40 (human), 35 (mouse) Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
Western Blotting
All Goat 

Product Description

The Pro-Survival Bcl-2 Family Antibody Sampler Kit provides an economical means to examine several members of the Bcl-2 family. The kit contains enough primary and secondary antibodies to perform four western blot experiments.


Specificity / Sensitivity

Each antibody in the Pro-Survival Bcl-2 Family Antibody Sampler Kit recognizes only its specific target. The antibodies do not cross-react with other Bcl-2 family members. Phospho-Bcl-2 (Ser70) (5H2) Rabbit mAb detects endogenous levels of human Bcl-2 only when phosphorylated at Ser70. Phospho-Bcl-2 (Thr56) Antibody (Human Specific) detects endogenous levels of human Bcl-2 only when phosphorylated at Thr56.


Source / Purification

Total Mcl-1, Bcl-xL, and Bcl-2 monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding Leu210 of human Mcl-1, Asp61 of human Bcl-xL, and residues at the carboxy terminus of human Bcl-2 alpha. Phospho-Bcl-2 (Ser70) (5H2) Rabbit mAb is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser70 of human Bcl-2. Phospho-Bcl-2 (Thr56) Antibody (Human Specific) is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr56 of human Bcl-2. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.

The Bcl-2 family consists of a number of evolutionarily conserved proteins containing Bcl-2 homology domains (BH) that regulate apoptosis through control of mitochondrial membrane permeability and release of cytochrome c (1-3). Four BH domains have been identified (BH1-4) that mediate protein interactions. The family can be separated into three groups based upon function and sequence homology: pro-survival members include Bcl-2, Bcl-xL, Mcl-1, A1 and Bcl-w; pro-apoptotic proteins include Bax, Bak and Bok, and "BH3 only" proteins Bad, Bik, Bid, Puma, Bim, Bmf, Noxa and Hrk. Interactions between death-promoting and death-suppressing Bcl-2 family members has led to a rheostat model in which the ratio of pro-apoptotic and anti-apoptotic proteins controls cell fate (4). Thus, pro-survival members exert their behavior by binding to and antagonizing death-promoting members. In general, the "BH3-only members" can bind to and antagonize the pro-survival proteins leading to increased apoptosis (5). While some redundancy of this system likely exists, tissue specificity, transcriptional and post-translational regulation of many of these family members can account for distinct physiological roles.


Several phosphorylation sites have been identified within Bcl-2 including Thr56, Ser70, Thr74 and Ser87 (6). These phosphorylation sites may be targets of the ASK1/MKK7/JNK1 pathway, and phosphorylation of Bcl-2 may be a marker for mitotic events (7,8). Mutation of Bcl-2 at Thr56 or Ser87 inhibits its anti-apoptotic activity during glucocorticoid-induced apoptosis of T lymphocytes (9). Interleukin 3 and JNK-induced Bcl-2 phosphorylation at Ser70 may be required for its enhanced antiapoptotic functions (10).


1.  Cory, S. et al. (2003) Oncogene 22, 8590-607.

2.  Antonsson, B. and Martinou, J.C. (2000) Exp Cell Res 256, 50-7.

3.  Sharpe, J.C. et al. (2004) Biochim Biophys Acta 1644, 107-13.

4.  Bouillet, P. and Strasser, A. (2002) J Cell Sci 115, 1567-74.

5.  Korsmeyer, S.J. et al. (1993) Semin Cancer Biol 4, 327-32.

6.  Maundrell, K. et al. (1997) J. Biol. Chem. 272, 25238-25242.

7.  Yamamoto, K. et al. (1999) Mol. Cell Biol. 19, 8469-8478.

8.  Ling, Y. H. et al. (1998) J. Biol. Chem. 273, 18984-18991.

9.  Huang, S.J. and Cidlowski, J.A. (2002) FASEB 16, 825-832.

10.  Deng, X. et al. (2001) J. Biol. Chem. 276, 23681-23688.


Entrez-Gene Id 598, 596, 4170
Swiss-Prot Acc. Q07817, P10415, Q07820


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
U.S. Patent No. 5,675,063.